Folks taking GLP-1 medicine like Ozempic for diabetes had been much less prone to be recognized with substance use dysfunction, a brand new examine reveals.
Maria Fabrizio for NPR
conceal caption
toggle caption
Maria Fabrizio for NPR
There’s new proof that GLP-1 medicine like Ozempic can scale back the chance of dependancy.
A study of greater than 600,000 veterans adopted for as much as 3 years discovered that those that began taking a GLP-1 drug for diabetes had been about 15% to twenty% much less prone to misuse substances starting from alcohol to opioids.
The examine, which seems in The BMJ, a medical journal, additionally discovered that GLP-1 medicine helped folks with a historical past of substance use dysfunction. They had been much less prone to expertise an overdose, drug-related hospitalization, drug-related demise or suicide try.
“The shock was that it was working throughout varied substances,” says Dr. Ziyad Al-Aly, an creator of the examine and a scientific epidemiologist at WashU Drugs in St. Louis.
That means a typical “biologic sign” affected by GLP-1 medicine is concerned in all addictive issues, says Al-Aly, who additionally holds a place at VA St. Louis Well being Care System.
The outcomes recommend that GLP-1 medicine might provide a brand new choice for the 48.4 million Americans with a substance use dysfunction.
However researchers warning that the examine, although massive, was not the form of managed scientific trial wanted to substantiate that GLP-1 medicine provide a protected and efficient strategy to deal with dependancy. Outcomes from a number of of these research are anticipated within the coming 12 months.
“We have now lots of hope that these medicines could also be useful,” says Dr. Lorenzo Leggio, an dependancy researcher on the Nationwide Institutes of Well being, who was not concerned within the examine.
“There’s each motive to be extremely enthusiastic,” says Dr. Klara Klein, an endocrinologist on the UNC Faculty of Drugs in Chapel Hill. “However these aren’t medicines which have been examined in individuals who do not have obese and weight problems, or Kind 2 diabetes.”
Sudden profit
The outcomes come after smaller studies and research on animals instructed that GLP-1 medicine might scale back the cravings for particular substances, together with alcohol and nicotine.
And ever since GLP-1 medicine started to achieve thousands and thousands of People in search of to drop a few pounds or management diabetes, medical doctors have been listening to intriguing stories from sure sufferers.
“They’d say, ‘I do not take care of alcohol anymore’ or ‘I ended smoking,'” Al-Aly says.
So he and a group determined to see whether or not these anecdotes had been supported by knowledge from VA sufferers. The scientists in contrast individuals who obtained GLP-1 medicine for his or her diabetes with individuals who obtained medicine that use a special mechanism to regulate blood sugar ranges.
The outcomes: GLP-1 customers and not using a historical past of substance abuse dysfunction had been much less prone to misuse substances together with alcohol, nicotine, hashish, cocaine and opioids. For many of those substances, the discount in danger was within the 15% to twenty% vary.
Amongst individuals who did have a historical past of substance abuse, those that obtained a GLP-1 drug had a 25% to 50% decrease danger for emergency departments visits, hospitalization, drug overdose, suicidal ideas or makes an attempt, and demise.
Some medicines, like naltrexone and buprenorphine, are used particularly to forestall relapse in folks attempting to get better from opioid use dysfunction. (Naltrexone can be utilized in alcohol use dysfunction.) However there’s at the moment no different drug available on the market that might do what GLP-1 medicine seem to do — forestall danger of dependancy extra usually.
GLP-1 medicine appear to struggle dependancy by decreasing the hormone dopamine in a mind system concerned in reward, motivation and stress — a system “that’s co-opted or hijacked, if you’ll, by dependancy,” Al-Aly says.
Nonetheless some questions
Previously decade, GLP-1 medicine have revolutionized weight reduction and diabetes therapy. However medical doctors are nonetheless studying how the medicine would possibly have an effect on, say, an individual who’s already skinny and has alcohol use dysfunction.
“In the event that they actually cease consuming, they lose lots of the energy that they consumption from alcohol,” Klein says. “That particular person would possibly lose actually lots of weight and endure nutritionally.”
It is also unclear how lengthy folks with substance use dysfunction would want to take a GLP-1 drug.
“My hope is that we’ll work out ways in which a teen will not must be on a medicine for the remainder of their lives,” Klein says.
Ongoing scientific trials will assist reply these questions, Leggio says. And in the event that they affirm that GLP-1 medicine are efficient for treating dependancy, he says, it might change the therapy panorama.
For the time being, he says, remedies are likely to concentrate on a single substance, like alcohol or nicotine.
That is an issue, although, as a result of “it is uncommon to see a affected person solely be addicted to at least one drug versus utilizing a number of medicine on the similar time,” Leggio says.
With GLP-1 medicine, he says, it might be potential to assist these folks with a single treatment.
